List of works - Krzysztof Sztanke

A Screen-Printed Sensor Coupled with Flow System for Quantitative Determination of a Novel Promising Anticancer Agent Candidate

scientific article published on 13 September 2020

A novel fused 1,2,4-triazine aryl derivative as antioxidant and nonselective antagonist of adenosine A(2A) receptors in ethanol-activated liver stellate cells

scientific article

A simple stripping voltammetric method for the determination of a new anticancer prodrug in serum.

scientific article published on 27 March 2017

An insight into synthetic Schiff bases revealing antiproliferative activities in vitro

scientific article published on 22 April 2013

Anticancer active trifluoromethylated fused triazinones are safe for early-life stages of zebrafish (<i>Danio rerio</i>) and reveal a proapoptotic action

scientific article published on 01 December 2021

Antimicrobial screening of certain fused 1,2,4-triazine derivatives.

scientific article

Antinociceptive activity of new imidazolidine carbonyl derivatives. Part 4. Synthesis and pharmacological activity of 8-aryl-3,4-dioxo-2H,8H-6,7-dihydroimidazo[2,1-c] [1,2,4]triazines

scientific article published in February 2005

Biologically and chemically important hydrazino-containing imidazolines as antioxidant agents

scientific article published on 01 June 2018

Biologically important hydrazide-containing fused azaisocytosines as antioxidant agents.

scientific article published on 16 August 2017

Crystal structure, antitumour and antimetastatic activities of disubstituted fused 1,2,4-triazinones

scientific article

Current trends in asthma therapy.

scientific article published in January 2003

Electron ionization mass spectra of 8-aryl-3,4-dioxo-2H,8H-6,7-dihydroimidazo[2,1-c][1,2,4]triazines. Do they exhibit tautomerism in the gas phase?

scientific article published on 01 January 2006

Exclusion of antimicrobial activity of some analgesic active imidazo[2,1-c][1,2,4]triazines

scientific article published on 01 January 2004

Exclusion of antimicrobial activity of some analgesic active imidazo[2,1-c]triazines.

scientific article

Identification of antibacterial and antiviral activities of novel fused 1,2,4-triazine esters.

scientific article

Identification of antitumour activity of novel derivatives of 8-aryl-2,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazine-3,4-dione and 8-aryl-4-imino-2,3,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3(6H)-one

scientific article published on 15 February 2007

In vitro effects of a new fused azaisocytosine-like congener on relative cell proliferation, necrosis and cell cycle in cancer and normal cell cultures.

scientific article

Lipophilicity of novel antitumour and analgesic active 8-aryl-2,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazine-3,4-dione derivatives determined by reversed-phase HPLC and computational methods.

scientific article

Novel derivatives of methyl and ethyl 2-(4-oxo-8-aryl-2H-3,4,6,7-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetates from biologically active 1-aryl-2-hydrazinoimidazolines: synthesis, crystal structure and antiproliferative activity

scientific article published on 22 September 2006

Oxazolidinones--a new class of broad-spectrum chemotherapeutics.

scientific article

Plasma matrix metalloproteinase 9 correlates with disorders of brain magnesium homeostasis in patients undergoing coronary artery bypass surgery

scientific article published on December 20, 2010

Predicting the Blood-Brain Barrier Permeability of New Drug-Like Compounds via HPLC with Various Stationary Phases

scientific article published on 23 January 2020

Reversed-phase liquid chromatography with octadecylsilyl, immobilized artificial membrane and cholesterol columns in correlation studies with in silico biological descriptors of newly synthesized antiproliferative and analgesic active compounds

scientific article published on 23 September 2013

Square-wave adsorptive stripping voltammetric approaches at two in situ modified electrodes as first analytical methods for the quantitative determination of a new anticancer drug candidate

Structure-retention behaviour of biologically active fused 1,2,4-triazinones--correlation with in silico molecular properties

scientific article published on 17 December 2014

Studies on the synthesis of new derivatives of 8-aryl-4-imino-2,3,7,8-tetrahydro-imidazo [2,1-c][1,2,4] triazin-3 (6H)-one with an expected biological activity.

scientific article

Synthesis of imidazoline and imidazo[2,1-c][1,2,4]triazole aryl derivatives containing the methylthio group as possible antibacterial agents

scientific article published on 7 February 2006

Synthesis of new derivatives of 3-methyl-8-aryl-7,8-dihydro-6H-imidazo[2,1-c][1,2,4] triazin-4-one

scientific article published in May 2002

Synthesis of new derivatives of 8-aryl-3-phenyl-6,7-dihydro-4H-imidazo[2, 1-c][1,2,4]triazin-4-one.

scientific article published in September 2004

Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate

scientific article published on 20 March 2006

Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.

scientific article

Synthesis, structure confirmation, identification of in vitro antiproliferative activities and correlation of determined lipophilicity parameters with in silico bioactivity descriptors of two novel classes of fused azaisocytosine-like congeners

scientific article published in December 2019

Synthesis, structure elucidation and identification of antiproliferative activities of a novel class of thiophene bioisosteres bearing the privileged 7,8-dihydroimidazo[2,1-c][1,2,4]triazin-4(6H)-one scaffold

scientific article published on 27 April 2015

Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives

scientific article published on 29 July 2007

Synthesis, structure elucidation and in vitro anticancer activities of novel derivatives of diethyl (2E)-2-[(2E)-(1-arylimidazolidin-2-ylidene)hydrazono]succinate and ethyl (4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetate

scientific article published on 25 September 2013

Synthesis, structure elucidation, determination of the lipophilicity and identification of antitumour activities in vitro of novel 3-(2-furanyl)-8-aryl-7,8-dihydroimidazo[2,1-c][1,2,4]triazin-4(6H)-ones with a low cytotoxicity towards normal [...]

scientific article

The Maillard reaction and its consequences for a living body.

scientific article published in January 2003

The Maillard reaction inhibitors and their biological and therapeutic significance

scientific article (publication date: 2003)

The influence of some promising fused azaisocytosine-containing congeners on zebrafish (Danio rerio) embryos/larvae and their antihaemolytic, antitumour and antiviral activities

scientific article published on 23 February 2019

The susceptibility of certain bacterial strains to imidazotriazine derivatives

scientific article

The susceptibility of certain microbial strains to fused 1,2,4-triazole derivatives.

scientific article

The susceptibility of certain microbial strains to some imidazoline derivatives

scientific article

Thermal behaviour of antiproliferative active 3-(2-furanyl)-8-aryl-7,8-dihydroimidazo[2,1-c][1,2,4]triazin-4(6H)-ones

Two novel classes of fused azaisocytosine-containing congeners as promising drug candidates: Design, synthesis as well as in vitro, ex vivo and in silico studies

scientific article published on 09 December 2019

Volatile anesthetics reduce biochemical markers of brain injury and brain magnesium disorders in patients undergoing coronary artery bypass graft surgery

scientific article published on 28 December 2011

List of works by Krzysztof Sztanke

A Screen-Printed Sensor Coupled with Flow System for Quantitative Determination of a Novel Promising Anticancer Agent Candidate

A novel fused 1,2,4-triazine aryl derivative as antioxidant and nonselective antagonist of adenosine A(2A) receptors in ethanol-activated liver stellate cells

A simple stripping voltammetric method for the determination of a new anticancer prodrug in serum.

An insight into synthetic Schiff bases revealing antiproliferative activities in vitro

Anticancer active trifluoromethylated fused triazinones are safe for early-life stages of zebrafish (<i>Danio rerio</i>) and reveal a proapoptotic action

Antimicrobial screening of certain fused 1,2,4-triazine derivatives.

Antinociceptive activity of new imidazolidine carbonyl derivatives. Part 4. Synthesis and pharmacological activity of 8-aryl-3,4-dioxo-2H,8H-6,7-dihydroimidazo[2,1-c] [1,2,4]triazines

Biologically and chemically important hydrazino-containing imidazolines as antioxidant agents

Biologically important hydrazide-containing fused azaisocytosines as antioxidant agents.

Crystal structure, antitumour and antimetastatic activities of disubstituted fused 1,2,4-triazinones

Current trends in asthma therapy.

Electron ionization mass spectra of 8-aryl-3,4-dioxo-2H,8H-6,7-dihydroimidazo[2,1-c][1,2,4]triazines. Do they exhibit tautomerism in the gas phase?

Exclusion of antimicrobial activity of some analgesic active imidazo[2,1-c][1,2,4]triazines

Exclusion of antimicrobial activity of some analgesic active imidazo[2,1-c]triazines.

Identification of antibacterial and antiviral activities of novel fused 1,2,4-triazine esters.

Identification of antitumour activity of novel derivatives of 8-aryl-2,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazine-3,4-dione and 8-aryl-4-imino-2,3,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3(6H)-one

In vitro effects of a new fused azaisocytosine-like congener on relative cell proliferation, necrosis and cell cycle in cancer and normal cell cultures.

Lipophilicity of novel antitumour and analgesic active 8-aryl-2,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazine-3,4-dione derivatives determined by reversed-phase HPLC and computational methods.

Novel derivatives of methyl and ethyl 2-(4-oxo-8-aryl-2H-3,4,6,7-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetates from biologically active 1-aryl-2-hydrazinoimidazolines: synthesis, crystal structure and antiproliferative activity

Oxazolidinones--a new class of broad-spectrum chemotherapeutics.

Plasma matrix metalloproteinase 9 correlates with disorders of brain magnesium homeostasis in patients undergoing coronary artery bypass surgery

Predicting the Blood-Brain Barrier Permeability of New Drug-Like Compounds via HPLC with Various Stationary Phases

Reversed-phase liquid chromatography with octadecylsilyl, immobilized artificial membrane and cholesterol columns in correlation studies with in silico biological descriptors of newly synthesized antiproliferative and analgesic active compounds

Square-wave adsorptive stripping voltammetric approaches at two in situ modified electrodes as first analytical methods for the quantitative determination of a new anticancer drug candidate

Structure-retention behaviour of biologically active fused 1,2,4-triazinones--correlation with in silico molecular properties

Studies on the synthesis of new derivatives of 8-aryl-4-imino-2,3,7,8-tetrahydro-imidazo [2,1-c][1,2,4] triazin-3 (6H)-one with an expected biological activity.

Synthesis of imidazoline and imidazo[2,1-c][1,2,4]triazole aryl derivatives containing the methylthio group as possible antibacterial agents

Synthesis of new derivatives of 3-methyl-8-aryl-7,8-dihydro-6H-imidazo[2,1-c][1,2,4] triazin-4-one

Synthesis of new derivatives of 8-aryl-3-phenyl-6,7-dihydro-4H-imidazo[2, 1-c][1,2,4]triazin-4-one.

Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate

Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.

Synthesis, structure confirmation, identification of in vitro antiproliferative activities and correlation of determined lipophilicity parameters with in silico bioactivity descriptors of two novel classes of fused azaisocytosine-like congeners

Synthesis, structure elucidation and identification of antiproliferative activities of a novel class of thiophene bioisosteres bearing the privileged 7,8-dihydroimidazo[2,1-c][1,2,4]triazin-4(6H)-one scaffold

Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives

Synthesis, structure elucidation and in vitro anticancer activities of novel derivatives of diethyl (2E)-2-[(2E)-(1-arylimidazolidin-2-ylidene)hydrazono]succinate and ethyl (4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetate

Synthesis, structure elucidation, determination of the lipophilicity and identification of antitumour activities in vitro of novel 3-(2-furanyl)-8-aryl-7,8-dihydroimidazo[2,1-c][1,2,4]triazin-4(6H)-ones with a low cytotoxicity towards normal [...]

The Maillard reaction and its consequences for a living body.

The Maillard reaction inhibitors and their biological and therapeutic significance

The influence of some promising fused azaisocytosine-containing congeners on zebrafish (Danio rerio) embryos/larvae and their antihaemolytic, antitumour and antiviral activities

The susceptibility of certain bacterial strains to imidazotriazine derivatives

The susceptibility of certain microbial strains to fused 1,2,4-triazole derivatives.

The susceptibility of certain microbial strains to some imidazoline derivatives

Thermal behaviour of antiproliferative active 3-(2-furanyl)-8-aryl-7,8-dihydroimidazo[2,1-c][1,2,4]triazin-4(6H)-ones

Two novel classes of fused azaisocytosine-containing congeners as promising drug candidates: Design, synthesis as well as in vitro, ex vivo and in silico studies

Volatile anesthetics reduce biochemical markers of brain injury and brain magnesium disorders in patients undergoing coronary artery bypass graft surgery